InsiderTrades

Form 4 for DLB Dolby Laboratories, Inc.

Accepted 2025-09-18 00:00:00 ET · period of report 2025-09-16 · accession 0001193125-25-207589 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DTI 2025-09-18 2025-09-16 DLB YEAMAN KEVIN J Pres, CEO, Dir M - OptEx $45.50 +25.0K 139.7K +22% +$1.14M
DTI 2025-09-18 2025-09-16 DLB YEAMAN KEVIN J Pres, CEO, Dir S - Sale+OE $71.66 -25.0K 114.7K -18% -$1.79M
DTI 2025-09-18 2025-09-16 DLB YEAMAN KEVIN J Pres, CEO, Dir M - OptEx $0.00 -25.0K 60.6K -29% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2025-09-16 M A 25,000 $45.50 139,725 I By a trust — — (F1) By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009
2 Common Class A Common Stock 2025-09-16 S D 25,000 $71.66 114,725 I By a trust — — (F2) The shares were sold in multiple transactions at prices ranging from $71.285 to $71.88, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. (F1) By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009
3 Derivative Employee Stock Option (Right to Buy) 2025-09-16 M D 25,000 $0.00 60,615 I By a trust $45.50 · — to 2026-12-15 25,000 Class A Common Stock (F1) By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 (F4) This option was granted for a total of 194,399 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date.